NONRHABDOMYOSARCOMA IN CHILDREN - PROGNOSTIC FACTORS INFLUENCING SURVIVAL

被引:34
作者
RAO, BN
机构
[1] Departments of Surgery, St. Jude Children's Research Hospital
[2] University of Tennessee, Memphis, Tennessee
来源
SEMINARS IN SURGICAL ONCOLOGY | 1993年 / 9卷 / 06期
关键词
PEDIATRIC CANCER; SYNOVIAL SARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; NEUROGENIC TUMORS; FIBROSARCOMA; ANGIOSARCOMA; ALVEOLAR SOFT PART SARCOMA; LEIOMYOSARCOMA;
D O I
10.1002/ssu.2980090611
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In approximately 90% of children with nonrhabdo soft tissue sarcoma (NRSTS) local control can be obtained by either surgery alone or with supplemental radiation. The disease-free survival is, however, only about 50%. To determine factors influencing overall survival, we undertook a retrospective review of the 154 children with NRSTS. We used the American Joint Committee on Cancer staging system (1988), using invasiveness, size, and a Pediatric Oncology Group grading system. Using this system we documented that 72 (46%) were noninvasive (T1) lesions. Of these 72 patients 50 (70%) were less-than-or-equal-to 5 cm A, and only 9 (18%) had G3 lesions. Overall 7/72 (10%) have died. In contrast to the 82 patients with invasive (T2) lesions, 65 (79%) were > 5 cm (B), with approximately 80% G3. Of all T2 lesions, 56/82 were G3 (65%). Here, overall 58/82 (70%) have died, primarily because 49/58 had G3 lesions. Important prognostic factors include primarily G3 lesion 52/71 (73%) mortality, as compared to 13/83 (15%), G1-2 dying. Children with invasive lesions tended to have larger tumors, 50/65, most of which were higher grades. We feel that patients with histologic grade G3 and T2 lesions should be enrolled in effective chemotherapy protocols. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:524 / 531
页数:8
相关论文
共 49 条
[1]  
Young JL, Ries LG, Silverberg E, Et al., Cancer incidence survival and mortality for children younger than age 15 yrs, Cancer, 58, pp. 595-602, (1986)
[2]  
Rao BN, Etcubanas EE, Green AA, Present day concepts in the management of sarcomas in children, Cancer Invest, 7, pp. 349-356, (1989)
[3]  
Miser JS, Pizzo PA, Soft tissue sarcomas in childhood, Pediatr Clin North Am, 32, pp. 779-800, (1985)
[4]  
Donaldson SS, The value of adjuvant chemotherapy in the management of sarcomas in children, Cancer, 55, pp. 2184-2197, (1985)
[5]  
Brennan MF, Management of soft tissue sarcoma, Aust NZ J Surg, 60, pp. 419-428, (1990)
[6]  
Liebel SA, Tranbaugh RF, Wara WM, Et al., Soft tissue sarcomas of the extremities, survival and patterns of failure with conservative surgery and post operative irradiation compared to surgery alone, Cancer, 50, pp. 1076-1083, (1982)
[7]  
Lawrence W, Neifield JP, Soft tissue sarcomas, Curr Probl Surg, 2, pp. 753-827, (1989)
[8]  
Tepper JE, Smith HD, The role of radiation therapy in the treatment of sarcoma of soft tissue, Cancer Invest, 3, pp. 587-592, (1985)
[9]  
Soft tissue sarcomas—pediatric, Manual for Staging of Cancer, pp. 275-280, (1988)
[10]  
Harmer MH, TNM Classification of Pediatric Tumors, pp. 23-28, (1982)